Posted on 4/23/20
IDEXX Laboratories: A Best-In-Breed Growth Company
SummaryIDEXX Laboratories sports an impressive return on invested capital and the business is benefiting from increased spending on pets.IDEXX shares have appreciated at a faster rate . . .
Posted on 4/23/20
1 Warren Buffett Stock That Looks Too Cheap to Ignore
To say that the stock market has been volatile would be a massive understatement, and very few stocks have been immune. Even some of the stocks . . .
Posted on 4/23/20
Is Deciphera Pharmaceuticals a Buy?
There are plenty of intriguing biotech stocks on the market right now, and many of them are trading at a steep discount due to the coronavirus . . .
Posted on 4/23/20
CVS Health Faces Rising Costs and Mounting Retail Collapse
In the past few years, CVS Health (NYSE:CVS) has ambitiously sought to expand into new markets to leverage its ubiquitous retail presence and universal brand awareness. . . .
Posted on 4/23/20
Here's How Thermo Fisher Scientific Beat Wall Street Expectations in Q1
Thermo Fisher Scientific (NYSE:TMO) hasn't been insulated from the impact of the coronavirus pandemic. Its shares were initially hit hard by the market sell-off caused by . . .
Posted on 4/23/20
Biogen Reports First-Quarter Results, Shares Plunge 9.4%
Biogen (NASDAQ:BIIB) released its first-quarter earnings report before the market opened on Wednesday, reporting $3.5 billion in revenue, a 1% year-over-year increase. Sales of the multiple . . .
Posted on 4/23/20
VBI Vaccines Prices $50M Public Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--VBI Vaccines Inc. (Nasdaq: VBIV) (VBI or the Company), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced the pricing . . .
Posted on 4/22/20
Cardiologs Launches Clinical Study to Monitor Cardiac Safety of COVID-19 Patients
Trial will evaluate use of Cardiologs’ AI platform for QT interval analysis of ECG data from smartwatches in patients receiving hydroxychloroquine treatmentCardiologs, a global leader in . . .
Posted on 4/22/20
Boston Scientific Closes New $1.25B Loan
Aimed at boosting liquidity, Boston Scientific (NYSE:BSX) entered into a new one-year $1.25B term loan yesterday that it used to refinance borrowings under its credit revolver. . . .
Posted on 4/22/20
Coronavirus Relief Survey: 84% of Americans Want Another Stimulus Check – WalletHub
The coronavirus pandemic has been one of the most disastrous events for the economy ever, already wiping out over 22 million jobs. In response to these . . .
Posted on 4/22/20
Cara Therapeutics Reports Success for Korsuva in Pivotal Trial
Shares of clinical-stage biotech Cara Therapeutics (NASDAQ:CARA) rose 4% Tuesday after the company reported successful results from a phase 3 trial of its lead drug Korsuva . . .
Posted on 4/22/20
Could CVS Health Be a Millionaire-Maker Stock?
The coronavirus pandemic thrust the entire healthcare system under a microscope. Now, daily news reports and conversations center around the number of hospital beds and ventilators, . . .
Posted on 4/22/20
Prospero Health Partners With GrandPad
BOSTON--(BUSINESS WIRE)--Prospero Health, a team-based home health care company, has partnered with GrandPad, the first purpose-built tablet for people over 75, to improve access to care . . .
Posted on 4/22/20
VBI Vaccines Announces Proposed Public Offering of Common Shares
CAMBRIDGE, Mass.--(BUSINESS WIRE)--VBI Vaccines Inc. (Nasdaq: VBIV), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced that it has commenced an underwritten . . .
Posted on 4/21/20
Mental Health Technologies Offers Free Online Anxiety and Depression Screening Service to the Public During COVID-19 Crisis
Assessments are anonymous, convenient and secure; free public service adheres to government stay-at-home mandates while providing access to critical mental health support Mental Health Technologies, Inc. . . .
Posted on 4/21/20
Bristol Myers Squibb's Cancer Drug Opdivo Successful in 2 Clinical Trials
Bristol Myers Squibb (NYSE:BMY) started off the week by delivering a double-dose of good news regarding its cancer drug Opdivo: In two late-stage clinical trials testing . . .
Posted on 4/21/20
7 Reasons to Buy Berkshire Hathaway and Never Sell
Long-term investors have been taken for quite the ride over the past two months. The proliferation of the coronavirus disease 2019 (COVID-19), which has been confirmed . . .
Posted on 4/21/20
Looks Like Berkshire Hathaway Isn’t Making Any Big Moves Just Yet
During the COVID-19 downturn, investors might have expected Warren Buffett's conglomerate Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) to put its massive $125 billion cash pile to work and . . .
Posted on 4/20/20
Novolex Repurposes to Manufacture Medical Protective Equipment
As healthcare professionals and first responders have come under increasing strain due to the COVID-19 crisis, Novolex has retooled its manufacturing capabilities and repurposed its supply . . .
Posted on 4/20/20
Better Buy: GlaxoSmithKline vs. Bristol Myers Squibb
If you're hunting for great stocks to buy while the market is still down, you'll definitely want to check out big pharma stocks. Many large drugmakers . . .
Posted on 4/20/20
Biogen Is Building a COVID-19 Biobank With the Broad Institute
One of the world's largest biotechnology companies is making the best of a bad situation with a little help from its neighbors. In partnership with the . . .
Posted on 4/20/20
3 Stocks Warren Buffett Wishes He Could Buy
Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) is currently worth more than $450 billion and literally has more than a hundred billion dollars to put to work. One downside . . .
Posted on 4/20/20
Boston Scientific Begins Selling Low-Cost Ventilator Alternative
Addressing an urgent need arising from the SARS-CoV-2 coronavirus outbreak and the COVID-19 disease that can result from it, Boston Scientific (NYSE:BSX) is manufacturing a new, . . .
Posted on 4/19/20
InVivo Therapeutics Closes $3M Registered Direct Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules of 1,715,240 shares . . .
Posted on 4/19/20
MedRhythms Announces an Expansion of Intellectual Property Portfolio
MedRhythms, a Portland, Maine-based company building direct stimulation digital therapeutics that use sensors, software, and music to measure and improve walking, announced today the issuance of . . .

